Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03154359 · ClinicalTrials.gov registry record
Atomoxetine PBPK-PD Clinical Study
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 51
- Enrollment target
NCT03154359 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 51 participants.
The verdict
NCT03154359 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The primary aims of this study focus on characterizing the relationship between atomoxetine exposure and clinical outcomes, as assessed by standardized measures. We will also simultaneously monitor side effect of atomoxetine, another measure of clinical outcomes, and categorize study participants on their ability to tolerate atomoxetine.
Interventions
- DRUG Atomoxetine Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2017-12-12 |
| Est. Completion | 2022-06-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03154359
The ClinicalTrials.gov registry entry for NCT03154359 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Atomoxetine Hydrochloride is the first listed.
NCT03154359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03154359 about?
NCT03154359 is a clinical study titled "Atomoxetine PBPK-PD Clinical Study". The primary aims of this study focus on characterizing the relationship between atomoxetine exposure and clinical outcomes, as assessed by standardized measures. We will also simultaneously monitor side effect of atomoxetine, another measure of clinical outcomes, and categorize study participants on...
What is the current status of trial NCT03154359?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2017-12-12. Estimated completion is 2022-06-16.
What interventions are being tested in trial NCT03154359?
The interventions under investigation include: Atomoxetine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT03154359?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.